Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials
Sign Up to like & getrecommendations! Published in 2024 at "Dermatology and Therapy"
DOI: 10.1007/s13555-024-01174-4
Abstract: The presence (vs absence) of enthesitis/dactylitis is associated with greater psoriatic arthritis (PsA) activity and reduced health-related quality of life. Risankizumab, an interleukin 23 antagonist, demonstrated superior treatment efficacy over placebo in patients with PsA,… read more here.
Keywords: week; dactylitis; resolution enthesitis; enthesitis dactylitis ... See more keywords